what on earth are you guys talking hype this and that. its...

what on earth are you guys talking hype this and that. its market cap is under 100mill and addition, the protocol design for the selection of patients
to participate in Cvac™’s Phase IIb/III Pivotal Trial has already been completed .

Dendreon’s market capitalisation has grown from US$600m to over US$2Bn over the
last month. It share price has risen sharply in recent weeks in anticipation of the
successful completion of its Pivotal Clinical Trial, which paves the way for it to
achieve commercialisation and become the world’s first US FDA-approved Cancer
vaccine immuno-therapy.

I DONT think people out there are aware of how close PRR are in their trials compared to Dendreon. after this trial starting june/july, PRR will apply for FDA approval. so how can dendreon be $2bill market cap and PRR 26mill now. DOnt you think PRR should be $500mill market cap at the end of these trials pending annc of WHAT DENDREON are waiting on tonight???

read this :

It has
completed two successful clinical trials and is in the final stages of US FDA approval
and eventual commercialisation.


FINAL STAGES : i repeat FINAL STAGES.

no-one will be getting my shares for another 2 years. pennies for dollars despite the bumps imo